Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus

The relationship between the renin–angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated...

Full description

Saved in:
Bibliographic Details
Published inJournal of diabetes and its complications Vol. 31; no. 10; pp. 1499 - 1505
Main Authors Min, Se Hee, Kong, Sung Hye, Lee, Jie-Eun, Lee, Dong-Hwa, Oh, Tae Jung, Kim, Kyoung Min, Park, Kyong Soo, Jang, Hak Chul, Lim, Soo
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2017
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The relationship between the renin–angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications. We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured. The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors. Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism. •Serum angiotensin-II concentration increases from prediabetic condition.•Serum angiotensin-II was independently associated with urine albumin excretion after adjusting for multiple risk factors.•Angiotensin-II plays a critical role in the pathophysiology of microvascular complications of diabetes.
AbstractList The relationship between the renin–angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications. We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured. The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors. Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism. •Serum angiotensin-II concentration increases from prediabetic condition.•Serum angiotensin-II was independently associated with urine albumin excretion after adjusting for multiple risk factors.•Angiotensin-II plays a critical role in the pathophysiology of microvascular complications of diabetes.
The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications.OBJECTIVESThe relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications.We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured.METHODSWe investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured.The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors.RESULTSThe mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors.Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism.CONCLUSIONSAngiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism.
Objectives The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications. Methods We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured. Results The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors. Conclusions Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism.
The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications. We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured. The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m , respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors. Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism.
Author Park, Kyong Soo
Kim, Kyoung Min
Lee, Dong-Hwa
Kong, Sung Hye
Jang, Hak Chul
Lim, Soo
Min, Se Hee
Lee, Jie-Eun
Oh, Tae Jung
Author_xml – sequence: 1
  givenname: Se Hee
  surname: Min
  fullname: Min, Se Hee
  organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea
– sequence: 2
  givenname: Sung Hye
  surname: Kong
  fullname: Kong, Sung Hye
  organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea
– sequence: 3
  givenname: Jie-Eun
  surname: Lee
  fullname: Lee, Jie-Eun
  organization: Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
– sequence: 4
  givenname: Dong-Hwa
  surname: Lee
  fullname: Lee, Dong-Hwa
  organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea
– sequence: 5
  givenname: Tae Jung
  surname: Oh
  fullname: Oh, Tae Jung
  organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea
– sequence: 6
  givenname: Kyoung Min
  surname: Kim
  fullname: Kim, Kyoung Min
  organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea
– sequence: 7
  givenname: Kyong Soo
  surname: Park
  fullname: Park, Kyong Soo
  organization: Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
– sequence: 8
  givenname: Hak Chul
  surname: Jang
  fullname: Jang, Hak Chul
  organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea
– sequence: 9
  givenname: Soo
  surname: Lim
  fullname: Lim, Soo
  email: limsoo@snu.ac.kr
  organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28797632$$D View this record in MEDLINE/PubMed
BookMark eNqNkV1rFDEUhoNU7If-hRLwxovOmsxHMgMiLaXqQsEbBe9CkjlTM2aSMclU9jf4p5t1d2_2psKBhOR533M47zk6cd4BQpeUrCih7P24GnsjtZ_mVUkoX5FcpHyBzmjLq6Jm5MdJvpOGFS0v-Sk6j3EkhLCmoa_QadnyjrOqPEN_b2L02shkvMN-wNI9GJ_AReOK9RpbeAQb8R-TfmJp1TIZtwQjsXE4LmoEnfafzodJWvxgF-0j4AmSVN6aOF3hOUAeVUGCeJX9e5w2M-ASHx4zbK1JS3yNXg7SRnizPy_Q9093326_FPdfP69vb-4LXTc0FVRVpNZ9LYnsFAAwqRRhqu0a0HUlSTPwqiGqHrhu2hJ6RjXv-2EANbQ1V1V1gd7tfOfgfy8Qk5hM1HkI6cAvUdCubBvSNSXP6NsjdPRLcHm6TNV5vXXbskxd7qlFTdCLOZhJho04rDkDH3aADj7GAIPQJv3beQrSWEGJ2KYqRnFIVWxTFSQX2crZkfzQ4Vnh9U6YQ4RHA0FEbcDpHEjI2Ynem-ctPh5ZaGuc0dL-gs3_GDwB0gPYgg
CitedBy_id crossref_primary_10_1016_j_scr_2021_102168
crossref_primary_10_1097_HJH_0000000000002444
crossref_primary_10_1002_cche_10351
crossref_primary_10_4103_pm_pm_169_19
crossref_primary_10_1016_j_cca_2025_120154
crossref_primary_10_1016_j_jdiacomp_2020_107574
crossref_primary_10_1007_s00394_021_02595_z
crossref_primary_10_1016_j_bone_2019_115041
crossref_primary_10_1080_21623945_2023_2249763
crossref_primary_10_1016_j_bcp_2023_115659
crossref_primary_10_3390_ijms231911203
Cites_doi 10.1016/S0140-6736(11)60784-8
10.2147/VHRM.S1905
10.2337/diab.25.10.969
10.1210/jcem-66-2-454
10.1373/clinchem.2008.118000
10.1016/S0140-6736(02)08090-X
10.1038/ki.1977.132
10.1111/j.1365-2265.1982.tb01588.x
10.1007/BF00280883
10.1152/physrev.1977.57.2.313
10.2337/diacare.28.1.164
10.1042/cs0560255
10.2337/diab.24.9.833
10.1111/j.1365-2796.1994.tb01080.x
10.1042/CS20130344
10.1016/j.atherosclerosis.2010.05.020
10.1001/archinte.1977.03630190020008
10.4239/wjd.v3.i1.1
10.1210/jc.2016-1002
10.1152/ajpcell.00287.2006
10.1016/j.mce.2012.05.017
10.1016/j.jacc.2005.05.051
10.2337/diabetes.54.6.1615
10.1517/14728222.11.8.1011
10.1016/S0140-6736(02)08089-3
10.1681/ASN.2006050517
10.1016/S0140-6736(99)12323-7
10.1093/ajh/2.5.382
10.7326/0003-4819-130-6-199903160-00002
10.1001/jama.286.15.1882
10.1016/j.bbadis.2013.08.006
10.1016/j.ijcard.2005.03.053
10.3803/EnM.2013.28.1.26
10.1507/endocrj.48.25
10.2337/dc16-S005
10.1046/j.1523-1755.2000.07715.x
ContentType Journal Article
Copyright 2017 Elsevier Inc.
Copyright © 2017 Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Oct 1, 2017
Copyright_xml – notice: 2017 Elsevier Inc.
– notice: Copyright © 2017 Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Oct 1, 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8AO
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AN0
ASE
AZQEC
BENPR
CCPQU
DWQXO
FPQ
FYUFA
GHDGH
GNUQQ
GUQSH
K6X
K9-
K9.
KB0
M0R
M0S
M1P
M2O
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1016/j.jdiacomp.2017.07.002
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
British Nursing Index
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
British Nursing Index (BNI) (1985 to Present)
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
British Nursing Index
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
ProQuest Health & Medical Collection
Medical Database
ProQuest research library
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
British Nursing Index
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

Research Library Prep
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1873-460X
EndPage 1505
ExternalDocumentID 28797632
10_1016_j_jdiacomp_2017_07_002
S1056872717303471
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29K
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8FI
8FJ
8G5
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ABUWG
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFKRA
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AN0
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BENPR
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BNQBC
BPHCQ
BVXVI
CCPQU
CS3
D-I
DU5
DWQXO
EBS
EFJIC
EFKBS
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HDZ
HMCUK
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
K9-
KOM
L7B
LZ1
M0R
M1P
M29
M2O
M41
MO0
N9A
NAPCQ
O-L
O9-
OAUVE
OB0
ON-
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
SV3
T5K
UKHRP
WOW
WUQ
Z5R
~G-
3V.
AACTN
AAIAV
ABLVK
ABYKQ
AFKWA
AJBFU
AJOXV
AMFUW
DOVZS
EFLBG
LCYCR
RIG
AAYXX
AFCTW
AGRNS
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
ASE
FPQ
K6X
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c451t-1b304cd4a0a9beee6abb06b895ec43a05f7350b4f7c582ed61c7ddffebf847b33
IEDL.DBID .~1
ISSN 1056-8727
1873-460X
IngestDate Mon Jul 21 11:40:12 EDT 2025
Fri Jul 25 02:43:57 EDT 2025
Wed Feb 19 02:41:19 EST 2025
Tue Jul 01 00:51:00 EDT 2025
Thu Apr 24 23:02:24 EDT 2025
Fri Feb 23 02:24:52 EST 2024
Tue Aug 26 16:31:51 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords albuminuria
ACE
type 2 diabetes
RAS
Angiotensin-II
ALT
Microvascular complications
Language English
License Copyright © 2017 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c451t-1b304cd4a0a9beee6abb06b895ec43a05f7350b4f7c582ed61c7ddffebf847b33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 28797632
PQID 1940564886
PQPubID 1226340
PageCount 7
ParticipantIDs proquest_miscellaneous_1928509527
proquest_journals_1940564886
pubmed_primary_28797632
crossref_citationtrail_10_1016_j_jdiacomp_2017_07_002
crossref_primary_10_1016_j_jdiacomp_2017_07_002
elsevier_sciencedirect_doi_10_1016_j_jdiacomp_2017_07_002
elsevier_clinicalkey_doi_10_1016_j_jdiacomp_2017_07_002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2017
2017-10-00
2017-Oct
20171001
PublicationDateYYYYMMDD 2017-10-01
PublicationDate_xml – month: 10
  year: 2017
  text: October 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Philadelphia
PublicationTitle Journal of diabetes and its complications
PublicationTitleAlternate J Diabetes Complications
PublicationYear 2017
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References Ribeiro-Oliveira, Nogueira, Pereira, Boas, Dos Santos, Simoes e Silva (bb0025) 2008; 4
Christlieb, Kaldany, D'Elia (bb0165) 1976; 25
Bae, Seo, Hur, Kim, Lee, Lee (bb0085) 2013; 28
Abuissa, Jones, Marso, O'Keefe (bb0050) 2005; 46
Mojahedi, Bonakdaran, Hami, Sheikhian, Shakeri, Aiatollahi (bb0135) 2009; 3
Patel, Parajuli, Oudit (bb0045) 2014; 126
Perez, Lespier, Jacobi, Oster, Katz, Vaamonde (bb0020) 1977; 137
Sasson, Cherney (bb0185) 2012; 3
Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (bb0080) 1985; 28
Sena, Pereira, Seica (bb0140) 2013; 1832
Lindholm, Ibsen, Dahlof, Devereux, Beevers, de Faire (bb0150) 2002; 359
Nicola, Sidhom, El Khyat, Ibrahim, Salah, El Sayed (bb0110) 2001; 48
Luetscher, Kraemer, Wilson (bb0035) 1989; 2
Yusuf, Gerstein, Hoogwerf, Pogue, Bosch, Wolffenbuttel (bb0060) 2001; 286
Campbell, Nussberger, Stowasser, Danser, Morganti, Frandsen (bb0070) 2009; 55
Muniyappa, Yavuz (bb0100) 2013; 378
Ferriss, Sullivan, Gonggrijp, Cole, O'Sullivan (bb0105) 1982; 17
Mehta, Griendling (bb0095) 2007; 292
Leehey, Singh, Alavi, Singh (bb0115) 2000; 77
Gossain, Werk, Sholiton, Srivastava, Knowles (bb0160) 1975; 24
American Diabetes Association (bb0065) 2016; 39
Mogensen (bb0180) 1994; 235
de Zeeuw, Parving, Henning (bb0190) 2006; 17
HOPE-Study (bb0055) 2000; 355
de Chatel, Weidmann, Flammer, Ziegler, Beretta-Piccoli, Vetter (bb0155) 1977; 12
Erdmann (bb0195) 2006; 107
Bryer-Ash, Fraze, Luetscher (bb0030) 1988; 66
Ling, Vamvakas, Schaefer, Schnittler, Schaefer, Heidland (bb0120) 1995; 10
Han, Liu, Liu, Li (bb0130) 2010; 212
Dahlof, Devereux, Kjeldsen, Julius, Beevers, de Faire (bb0145) 2002; 359
Joseph, Echouffo-Tcheugui, Kalyani, Yeh, Bertoni, Effoe (bb0170) 2016; 101
Peach (bb0040) 1977; 57
Levey, Bosch, Lewis, Greene, Rogers, Roth (bb0075) 1999; 130
(bb0005) 2015
Tojo, Asaba, Onozato (bb0125) 2007; 11
Gross, de Azevedo, Silveiro, Canani, Caramori, Zelmanovitz (bb0175) 2005; 28
Blaha, Budoff, DeFilippis, Blankstein, Rivera, Agatston (bb0090) 2011; 378
Brownlee (bb0010) 2005; 54
Burden, Thurston (bb0015) 1979; 56
Matthews (10.1016/j.jdiacomp.2017.07.002_bb0080) 1985; 28
Sasson (10.1016/j.jdiacomp.2017.07.002_bb0185) 2012; 3
Lindholm (10.1016/j.jdiacomp.2017.07.002_bb0150) 2002; 359
(10.1016/j.jdiacomp.2017.07.002_bb0005) 2015
Bryer-Ash (10.1016/j.jdiacomp.2017.07.002_bb0030) 1988; 66
Joseph (10.1016/j.jdiacomp.2017.07.002_bb0170) 2016; 101
de Chatel (10.1016/j.jdiacomp.2017.07.002_bb0155) 1977; 12
de Zeeuw (10.1016/j.jdiacomp.2017.07.002_bb0190) 2006; 17
Ribeiro-Oliveira (10.1016/j.jdiacomp.2017.07.002_bb0025) 2008; 4
Campbell (10.1016/j.jdiacomp.2017.07.002_bb0070) 2009; 55
Dahlof (10.1016/j.jdiacomp.2017.07.002_bb0145) 2002; 359
Burden (10.1016/j.jdiacomp.2017.07.002_bb0015) 1979; 56
Ferriss (10.1016/j.jdiacomp.2017.07.002_bb0105) 1982; 17
Sena (10.1016/j.jdiacomp.2017.07.002_bb0140) 2013; 1832
Gross (10.1016/j.jdiacomp.2017.07.002_bb0175) 2005; 28
HOPE-Study (10.1016/j.jdiacomp.2017.07.002_bb0055) 2000; 355
Mehta (10.1016/j.jdiacomp.2017.07.002_bb0095) 2007; 292
Yusuf (10.1016/j.jdiacomp.2017.07.002_bb0060) 2001; 286
Nicola (10.1016/j.jdiacomp.2017.07.002_bb0110) 2001; 48
Christlieb (10.1016/j.jdiacomp.2017.07.002_bb0165) 1976; 25
Han (10.1016/j.jdiacomp.2017.07.002_bb0130) 2010; 212
Muniyappa (10.1016/j.jdiacomp.2017.07.002_bb0100) 2013; 378
Brownlee (10.1016/j.jdiacomp.2017.07.002_bb0010) 2005; 54
Tojo (10.1016/j.jdiacomp.2017.07.002_bb0125) 2007; 11
Levey (10.1016/j.jdiacomp.2017.07.002_bb0075) 1999; 130
Gossain (10.1016/j.jdiacomp.2017.07.002_bb0160) 1975; 24
Perez (10.1016/j.jdiacomp.2017.07.002_bb0020) 1977; 137
Erdmann (10.1016/j.jdiacomp.2017.07.002_bb0195) 2006; 107
Mojahedi (10.1016/j.jdiacomp.2017.07.002_bb0135) 2009; 3
Patel (10.1016/j.jdiacomp.2017.07.002_bb0045) 2014; 126
Luetscher (10.1016/j.jdiacomp.2017.07.002_bb0035) 1989; 2
Bae (10.1016/j.jdiacomp.2017.07.002_bb0085) 2013; 28
Mogensen (10.1016/j.jdiacomp.2017.07.002_bb0180) 1994; 235
Peach (10.1016/j.jdiacomp.2017.07.002_bb0040) 1977; 57
Abuissa (10.1016/j.jdiacomp.2017.07.002_bb0050) 2005; 46
American Diabetes Association (10.1016/j.jdiacomp.2017.07.002_bb0065) 2016; 39
Leehey (10.1016/j.jdiacomp.2017.07.002_bb0115) 2000; 77
Blaha (10.1016/j.jdiacomp.2017.07.002_bb0090) 2011; 378
Ling (10.1016/j.jdiacomp.2017.07.002_bb0120) 1995; 10
References_xml – volume: 101
  start-page: 1770
  year: 2016
  end-page: 1778
  ident: bb0170
  article-title: Aldosterone, renin, and diabetes mellitus in African Americans: the Jackson heart study
  publication-title: J Clin Endocrinol Metab
– volume: 17
  start-page: 261
  year: 1982
  end-page: 269
  ident: bb0105
  article-title: Plasma angiotensin II and aldosterone in unselected diabetic patients
  publication-title: Clin Endocrinol
– volume: 4
  start-page: 787
  year: 2008
  end-page: 803
  ident: bb0025
  article-title: The renin-angiotensin system and diabetes: an update
  publication-title: Vasc Health Risk Manag
– volume: 48
  start-page: 25
  year: 2001
  end-page: 31
  ident: bb0110
  article-title: Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy
  publication-title: Endocr J
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  ident: bb0080
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
– volume: 66
  start-page: 454
  year: 1988
  end-page: 458
  ident: bb0030
  article-title: Plasma renin and prorenin (inactive renin) in diabetes mellitus: effects of intravenous furosemide
  publication-title: J Clin Endocrinol Metab
– volume: 212
  start-page: 206
  year: 2010
  end-page: 212
  ident: bb0130
  article-title: Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells
  publication-title: Atherosclerosis
– volume: 107
  start-page: 147
  year: 2006
  end-page: 153
  ident: bb0195
  article-title: Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes
  publication-title: Int J Cardiol
– volume: 137
  start-page: 852
  year: 1977
  end-page: 855
  ident: bb0020
  article-title: Hyporeninemia and hypoaldosteronism in diabetes mellitus
  publication-title: Arch Intern Med
– volume: 77
  start-page: S93
  year: 2000
  end-page: S98
  ident: bb0115
  article-title: Role of angiotensin II in diabetic nephropathy
  publication-title: Kidney Int Suppl
– volume: 359
  start-page: 995
  year: 2002
  end-page: 1003
  ident: bb0145
  article-title: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  publication-title: Lancet
– volume: 46
  start-page: 821
  year: 2005
  end-page: 826
  ident: bb0050
  article-title: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials
  publication-title: J Am Coll Cardiol
– volume: 39
  start-page: S13
  year: 2016
  end-page: S22
  ident: bb0065
  article-title: 2. Classification and diagnosis of diabetes
  publication-title: Diabetes Care
– volume: 10
  start-page: 1305
  year: 1995
  end-page: 1312
  ident: bb0120
  article-title: Angiotensin-II-induced cell hypertrophy: potential role of impaired proteolytic activity in cultured LLC-PK1 cells
  publication-title: Nephrol Dial Transplant
– volume: 126
  start-page: 471
  year: 2014
  end-page: 482
  ident: bb0045
  article-title: Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications
  publication-title: Clin Sci (Lond)
– volume: 292
  start-page: C82
  year: 2007
  end-page: C97
  ident: bb0095
  article-title: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
  publication-title: Am J Phys Cell Phys
– volume: 3
  start-page: 1
  year: 2012
  end-page: 6
  ident: bb0185
  article-title: Renal hyperfiltration related to diabetes mellitus and obesity in human disease
  publication-title: World J Diabetes
– volume: 54
  start-page: 1615
  year: 2005
  end-page: 1625
  ident: bb0010
  article-title: The pathobiology of diabetic complications: a unifying mechanism
  publication-title: Diabetes
– volume: 28
  start-page: 26
  year: 2013
  end-page: 32
  ident: bb0085
  article-title: Association between serum albumin, insulin resistance, and incident diabetes in nondiabetic subjects
  publication-title: Endocrinol Metab (Seoul)
– volume: 55
  start-page: 867
  year: 2009
  end-page: 877
  ident: bb0070
  article-title: Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement
  publication-title: Clin Chem
– volume: 2
  start-page: 382
  year: 1989
  end-page: 386
  ident: bb0035
  article-title: Prorenin and vascular complications of diabetes
  publication-title: Am J Hypertens
– volume: 57
  start-page: 313
  year: 1977
  end-page: 370
  ident: bb0040
  article-title: Renin-angiotensin system: biochemistry and mechanisms of action
  publication-title: Physiol Rev
– volume: 3
  start-page: 12
  year: 2009
  end-page: 16
  ident: bb0135
  article-title: Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus
  publication-title: Iran J Kidney Dis
– year: 2015
  ident: bb0005
  publication-title: IDF Diabetes
– volume: 24
  start-page: 833
  year: 1975
  end-page: 835
  ident: bb0160
  article-title: Plasma renin activity in juvenile diabetes mellitus and effect of diazoxide
  publication-title: Diabetes
– volume: 130
  start-page: 461
  year: 1999
  end-page: 470
  ident: bb0075
  article-title: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group
  publication-title: Ann Intern Med
– volume: 25
  start-page: 969
  year: 1976
  end-page: 974
  ident: bb0165
  article-title: Plasma renin activity and hypertension in diabetes mellitus
  publication-title: Diabetes
– volume: 286
  start-page: 1882
  year: 2001
  end-page: 1885
  ident: bb0060
  article-title: Ramipril and the development of diabetes
  publication-title: JAMA
– volume: 28
  start-page: 164
  year: 2005
  end-page: 176
  ident: bb0175
  article-title: Diabetic nephropathy: diagnosis, prevention, and treatment
  publication-title: Diabetes Care
– volume: 56
  start-page: 255
  year: 1979
  end-page: 259
  ident: bb0015
  article-title: Plasma renin activity in diabetes mellitus
  publication-title: Clin Sci (Lond)
– volume: 355
  start-page: 253
  year: 2000
  end-page: 259
  ident: bb0055
  article-title: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators
  publication-title: Lancet
– volume: 378
  start-page: 684
  year: 2011
  end-page: 692
  ident: bb0090
  article-title: Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
  publication-title: Lancet
– volume: 1832
  start-page: 2216
  year: 2013
  end-page: 2231
  ident: bb0140
  article-title: Endothelial dysfunction - a major mediator of diabetic vascular disease
  publication-title: Biochim Biophys Acta
– volume: 378
  start-page: 59
  year: 2013
  end-page: 69
  ident: bb0100
  article-title: Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act
  publication-title: Mol Cell Endocrinol
– volume: 11
  start-page: 1011
  year: 2007
  end-page: 1018
  ident: bb0125
  article-title: Suppressing renal NADPH oxidase to treat diabetic nephropathy
  publication-title: Expert Opin Ther Targets
– volume: 235
  start-page: 297
  year: 1994
  end-page: 316
  ident: bb0180
  article-title: Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension
  publication-title: J Intern Med
– volume: 359
  start-page: 1004
  year: 2002
  end-page: 1010
  ident: bb0150
  article-title: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  publication-title: Lancet
– volume: 12
  start-page: 412
  year: 1977
  end-page: 421
  ident: bb0155
  article-title: Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus
  publication-title: Kidney Int
– volume: 17
  start-page: 2100
  year: 2006
  end-page: 2105
  ident: bb0190
  article-title: Microalbuminuria as an early marker for cardiovascular disease
  publication-title: J Am Soc Nephrol
– volume: 378
  start-page: 684
  year: 2011
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0090
  article-title: Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60784-8
– volume: 4
  start-page: 787
  year: 2008
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0025
  article-title: The renin-angiotensin system and diabetes: an update
  publication-title: Vasc Health Risk Manag
  doi: 10.2147/VHRM.S1905
– volume: 25
  start-page: 969
  year: 1976
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0165
  article-title: Plasma renin activity and hypertension in diabetes mellitus
  publication-title: Diabetes
  doi: 10.2337/diab.25.10.969
– volume: 66
  start-page: 454
  year: 1988
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0030
  article-title: Plasma renin and prorenin (inactive renin) in diabetes mellitus: effects of intravenous furosemide
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-66-2-454
– volume: 55
  start-page: 867
  year: 2009
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0070
  article-title: Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2008.118000
– volume: 359
  start-page: 1004
  year: 2002
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0150
  article-title: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08090-X
– volume: 12
  start-page: 412
  year: 1977
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0155
  article-title: Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus
  publication-title: Kidney Int
  doi: 10.1038/ki.1977.132
– year: 2015
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0005
– volume: 17
  start-page: 261
  year: 1982
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0105
  article-title: Plasma angiotensin II and aldosterone in unselected diabetic patients
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.1982.tb01588.x
– volume: 28
  start-page: 412
  year: 1985
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0080
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 10
  start-page: 1305
  year: 1995
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0120
  article-title: Angiotensin-II-induced cell hypertrophy: potential role of impaired proteolytic activity in cultured LLC-PK1 cells
  publication-title: Nephrol Dial Transplant
– volume: 57
  start-page: 313
  year: 1977
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0040
  article-title: Renin-angiotensin system: biochemistry and mechanisms of action
  publication-title: Physiol Rev
  doi: 10.1152/physrev.1977.57.2.313
– volume: 28
  start-page: 164
  year: 2005
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0175
  article-title: Diabetic nephropathy: diagnosis, prevention, and treatment
  publication-title: Diabetes Care
  doi: 10.2337/diacare.28.1.164
– volume: 56
  start-page: 255
  year: 1979
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0015
  article-title: Plasma renin activity in diabetes mellitus
  publication-title: Clin Sci (Lond)
  doi: 10.1042/cs0560255
– volume: 24
  start-page: 833
  year: 1975
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0160
  article-title: Plasma renin activity in juvenile diabetes mellitus and effect of diazoxide
  publication-title: Diabetes
  doi: 10.2337/diab.24.9.833
– volume: 235
  start-page: 297
  year: 1994
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0180
  article-title: Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.1994.tb01080.x
– volume: 126
  start-page: 471
  year: 2014
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0045
  article-title: Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications
  publication-title: Clin Sci (Lond)
  doi: 10.1042/CS20130344
– volume: 212
  start-page: 206
  year: 2010
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0130
  article-title: Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2010.05.020
– volume: 137
  start-page: 852
  year: 1977
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0020
  article-title: Hyporeninemia and hypoaldosteronism in diabetes mellitus
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1977.03630190020008
– volume: 3
  start-page: 1
  year: 2012
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0185
  article-title: Renal hyperfiltration related to diabetes mellitus and obesity in human disease
  publication-title: World J Diabetes
  doi: 10.4239/wjd.v3.i1.1
– volume: 101
  start-page: 1770
  year: 2016
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0170
  article-title: Aldosterone, renin, and diabetes mellitus in African Americans: the Jackson heart study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-1002
– volume: 292
  start-page: C82
  year: 2007
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0095
  article-title: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
  publication-title: Am J Phys Cell Phys
  doi: 10.1152/ajpcell.00287.2006
– volume: 378
  start-page: 59
  year: 2013
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0100
  article-title: Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act
  publication-title: Mol Cell Endocrinol
  doi: 10.1016/j.mce.2012.05.017
– volume: 46
  start-page: 821
  year: 2005
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0050
  article-title: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2005.05.051
– volume: 54
  start-page: 1615
  year: 2005
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0010
  article-title: The pathobiology of diabetic complications: a unifying mechanism
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.6.1615
– volume: 11
  start-page: 1011
  year: 2007
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0125
  article-title: Suppressing renal NADPH oxidase to treat diabetic nephropathy
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728222.11.8.1011
– volume: 359
  start-page: 995
  year: 2002
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0145
  article-title: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08089-3
– volume: 17
  start-page: 2100
  year: 2006
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0190
  article-title: Microalbuminuria as an early marker for cardiovascular disease
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2006050517
– volume: 355
  start-page: 253
  year: 2000
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0055
  article-title: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators
  publication-title: Lancet
  doi: 10.1016/S0140-6736(99)12323-7
– volume: 2
  start-page: 382
  year: 1989
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0035
  article-title: Prorenin and vascular complications of diabetes
  publication-title: Am J Hypertens
  doi: 10.1093/ajh/2.5.382
– volume: 130
  start-page: 461
  year: 1999
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0075
  article-title: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-130-6-199903160-00002
– volume: 3
  start-page: 12
  year: 2009
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0135
  article-title: Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus
  publication-title: Iran J Kidney Dis
– volume: 286
  start-page: 1882
  year: 2001
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0060
  article-title: Ramipril and the development of diabetes
  publication-title: JAMA
  doi: 10.1001/jama.286.15.1882
– volume: 1832
  start-page: 2216
  year: 2013
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0140
  article-title: Endothelial dysfunction - a major mediator of diabetic vascular disease
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbadis.2013.08.006
– volume: 107
  start-page: 147
  year: 2006
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0195
  article-title: Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2005.03.053
– volume: 28
  start-page: 26
  year: 2013
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0085
  article-title: Association between serum albumin, insulin resistance, and incident diabetes in nondiabetic subjects
  publication-title: Endocrinol Metab (Seoul)
  doi: 10.3803/EnM.2013.28.1.26
– volume: 48
  start-page: 25
  year: 2001
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0110
  article-title: Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy
  publication-title: Endocr J
  doi: 10.1507/endocrj.48.25
– volume: 39
  start-page: S13
  year: 2016
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0065
  article-title: 2. Classification and diagnosis of diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc16-S005
– volume: 77
  start-page: S93
  year: 2000
  ident: 10.1016/j.jdiacomp.2017.07.002_bb0115
  article-title: Role of angiotensin II in diabetic nephropathy
  publication-title: Kidney Int Suppl
  doi: 10.1046/j.1523-1755.2000.07715.x
SSID ssj0006551
Score 2.235031
Snippet The relationship between the renin–angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components...
The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components...
Objectives The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1499
SubjectTerms Aged
albuminuria
Albuminuria - blood
Albuminuria - complications
Albuminuria - immunology
Albuminuria - metabolism
Angiotensin II - blood
Angiotensin-II
Biomarkers
Blood pressure
Cross-Sectional Studies
Diabetes
Diabetes Mellitus, Type 2 - complications
Diabetic Angiopathies - complications
Diabetic Angiopathies - diagnosis
Diabetic Angiopathies - epidemiology
Diabetic Angiopathies - physiopathology
Diabetic Nephropathies - blood
Diabetic Nephropathies - complications
Diabetic Nephropathies - immunology
Diabetic Nephropathies - metabolism
Early Diagnosis
Endothelium, Vascular - immunology
Endothelium, Vascular - physiopathology
Female
Glucose
Hospitals, University
Humans
Insulin Resistance
Kinases
Male
Metabolism
Microvascular complications
Microvessels - immunology
Microvessels - physiopathology
Middle Aged
Mortality
Outpatient Clinics, Hospital
Peptides
Prediabetic State - complications
RAS
Republic of Korea - epidemiology
Risk Factors
type 2 diabetes
Up-Regulation
Vasculitis - complications
Vasculitis - diagnosis
Vasculitis - epidemiology
Vasculitis - physiopathology
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagSIgL4t2FgozEsaGJH7FzQghRtUjlRKW9WXbioF2lztJsfgV_mpnEDj0A5Zp4rMQznvk8_uwh5J2urHMAOzJwfHUmKsszp12TMZe3lVVNU0ypi4uv5dml-LKW65hwGyKtMvnEyVE3fY058hNYbEOsBnMrP-x-ZFg1CndXYwmNu-QeXl2GlC61XhZcEF2n8otYXB5mPVM3Tghv329h_JG2jfQuNV3gGVMrfwhOfwOfUxA6fUQeRvRIP87qfkzu-PCE3L-I--NPyc8bo037ltrwfdNPHPWQnZ_TDhlCA8XcK514yZswggHSTaDD6DAjE18GRLIdjXx2euX3YCvdZrg6prtrn_K1x9B_QzGJSxlND6FxB9B-HJ6Ry9PP3z6dZbHcQlYLWeyzwvFc1I2wua2c974ELeal05X0teA2l63iMneiVbXUzDdlUYMu29a7FkKc4_w5OQh98IeEWuGF1bypJIP2EpTPLROal1XhtNJuRWQaZ1PHu8ixJEZnEulsa5J-DOrH5LhNzlbkZJHbzbdx3CqhkhpNOmsK3tFAwLhVslokIxqZUcZ_yR4lizHRJwzmtwWvyNvlNcxm3KKxwfcjtmEaIJxkakVezJa2_CisbQE7cvby352_Ig_wS2bC4RE52F-P_jUAp717M82OX0FoGmg
  priority: 102
  providerName: ProQuest
Title Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1056872717303471
https://dx.doi.org/10.1016/j.jdiacomp.2017.07.002
https://www.ncbi.nlm.nih.gov/pubmed/28797632
https://www.proquest.com/docview/1940564886
https://www.proquest.com/docview/1928509527
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Na9wwEBUhhdJL6Xe3TYMKPUZZ25Is-ZiGhN2WLKVtYG9GsuXixfEu8fraP5A_nRlZ3qbQkkIvNrZnjK0ZzzyPniRCPujMWAuwg0HgK5jIDGdW25IlNqoyo8oy9qWLi0U6uxSflnK5R07HsTBIqwyxf4jpPlqHM9PQmtNNXU-_4ZrxGtJvDE7KhR9HLoRCLz_--YvmkUq_BCMKM5S-M0p4dbwCGyB1Gyleyk_iGcorf0hQfwOgPhGdPyGPA4KkJ8NDPiV7rn1GHl6EPvLn5OZOi9N1RU37o157nnrL5nPaIEuoo1h_pZ6bXLc9OCGtW9r1Fqsy4WKLaLahgdNOr9wW_KWpu6sjurl2Y832CO5fUizk0oSOJ0G4AXjfdy_I5fnZ99MZC0susELIeMtiyyNRlMJEJrPOuRQsGaVWZ9IVgptIVorLyIpKFVInrkzjAuxZVc5WkOYs5y_Jfrtu3WtCjXDCaF5mMgF5CQ7ATSI0T7PYaqXthMixnfMizEeOy2I0-Ug8W-WjfXK0Tx5hV3kyIdOd3maYkeNeDTWaMR_Hm0KEzCFp3KuZ7TR_88p_0j0YPSYPcaHL4wwAcgpBM52Q97vL8EVjN41p3bpHmUQDjJOJmpBXg6ftXhT-bwE_8uTNfzzYW_IIjwZG4gHZ31737h0gq6099J8ObNVSHZIHJ_PPswXsP54tvny9Bc6BKOM
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VWwm4oPLs0gJGgltDE8fO44AQj1a7tLtCqJV6M3bioF2lydJshPgN_Bd-I-PEDj0A5dJr7ImczPjzN-OxB-B5kkqlkHZ4CHyZx1IZeipRuUeVX6QyzvOgC13M5tHklH0442cb8NOdhTFplQ4TO6DO68zEyPfR2ca1Gs0ter366pmqUWZ31ZXQ6M3iSH__hi5b82r6HvX7gtLDg5N3E89WFfAyxoO1Fyj04LOcSV-mSmsd4WD9SCUp1xkLpc-LOOS-YkWc8YTqPAoyHHJRaFUgkisTAEXI32QhujIj2Hx7MP_4acD-iHcFH005e8QZGl86k7x8uUSNm0Rxk1AWd1eG2mDOH5bDv9Hdbtk73ILblq-SN72B3YENXd2FGzO7I38PflzSL6kLIqsvi7rLiq-86ZSUJiepISbaS7pM6EXVosmTRUWaVpkYkG2sDHcuic2gJ-d6jdZZLprzPbK60C5CvIfvz4kJGxNK3EPsXKIz0Tb34fRaVPEARlVd6W0gkmkmkzBPOcX-HM0tlJQlYZQGKokTNQbu_rPI7O3npghHKVya21I4_QijH-GbjXk6hv1BbtXf_3GlROzUKNzpVsRjgUvUlZLpIGn5T89r_kt211mMsCjUiN9zZgzPhmbED7MpJCtdt6YPTZA0chqP4WFvacOHojeNbDWkj_798qdwc3IyOxbH0_nRDtwyo-rTHXdhtL5o9WOkbWv1xM4VAp-ve3r-AqW5Wvc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlVcEOW5tICR4FaziWPncUAIUVZdSisOVNqbsRMH7SpNlmYjxG_gH_HrmEns0ANQLr3GnsjJvMefPYQ8TzNtDIQdDAxfzkSmI2ZSUzBugjLTSVGEfeni5DQ-OhPvF3KxRX76szAIq_Q2sTfURZNjjXwKyTb4ahC3eFo6WMTHw9nr9VeGHaRwp9W30xhE5Nh-_wbpW_tqfgi8fsH57N2nt0fMdRhguZDhhoUGsvm8EDrQmbHWxrDwIDZpJm0uIh3IMolkYESZ5DLltojDHJZfltaUYNUNFkPB_N-ASSHqWLIYkz3w7H3rR2xsDxaHJ5dOJ69eroD3CBlHaFnSXx7qyjp_cIx_C3x7Bzi7TW65yJW-GURtl2zZ-g7ZOXF783fJj0ucpk1Jdf1l2fT4-JrN57RCdFJLse5Le0z0su5A-Omypm1nsBrkBmuMoivqsPT03G5ATqtle35A1xfW14oP4P0FxQIy5dQ_hMkVpBVde4-cXQsj7pPtuqntQ0K1sEKnUZFJDvMlCF6kuUijOAtNmqRmQqT_zyp396BjO45KecDbSnn-KOSPCnCLnk_IdKRbDzeBXEmReDYqf84VLLMCZ3UlZTZSukhoiHD-i3bfS4xy9qhVv7VnQp6Nw2BJcHtI17bpcA5PIXyUPJmQB4OkjR8KeTXErRF_9O-XPyU7oJTqw_z0eI_cxEUNuMd9sr256OxjiN825kmvKJR8vm7N_AWr_F3H
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+angiotensin-II+levels+with+albuminuria+in+subjects+with+normal+glucose+metabolism%2C+prediabetes%2C+and+type+2+diabetes+mellitus&rft.jtitle=Journal+of+diabetes+and+its+complications&rft.au=Min%2C+Se+Hee&rft.au=Kong%2C+Sung+Hye&rft.au=Lee%2C+Jie-Eun&rft.au=Lee%2C+Dong-Hwa&rft.date=2017-10-01&rft.issn=1873-460X&rft.eissn=1873-460X&rft.volume=31&rft.issue=10&rft.spage=1499&rft_id=info:doi/10.1016%2Fj.jdiacomp.2017.07.002&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1056-8727&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1056-8727&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1056-8727&client=summon